Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
The regulatory architecture of breast cancer is extraordinarily complex and gene misregulation can occur at many levels, with transcriptional malfunction being a major cause. This dysfunctional process typically involves additional regulatory modulators including DNA methylation. Thus, the interplay...
Main Authors: | Matthew H Ung, Frederick S Varn, Shaoke Lou, Chao Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-05-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC4440643?pdf=render |
Similar Items
-
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
by: Frederick S. Varn, et al.
Published: (2016-01-01) -
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
by: Kenneth M. K. Mark, et al.
Published: (2017-05-01) -
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation
by: Rajbir Nath Batra, et al.
Published: (2021-09-01) -
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
by: Frederick S. Varn, et al.
Published: (2018-06-01) -
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
by: Soledad Gómez, et al.
Published: (2015-09-01)